HIBAPRESS
The Minister of Health and Social Protection, Amin Tahraoui, chaired on Wednesday, January 28, 2026, the ordinary session of the Board of Directors of the Serum and Vaccine Center, known as the "Pasteur Institute of Morocco," in the presence of the Center's Director, Professor Abd al-Rahman al-Maaroufi, and members of the Board of Directors.
This meeting was a platform to evaluate the Institute's performance and anticipate its future prospects. The session's work was dedicated to studying the performance report for the year 2024, in addition to presenting the results of the external audit of the Institute's accounts for the years 2023 and 2024. The recommendations of the Scientific and Technical Committee were also reviewed, within the framework of an approach aimed at consolidating the principles of good governance and enhancing transparency and efficiency in management. The Council also discussed the initial orientations of the Institute's new economic model for the period 2026–2030, within a vision that aims to achieve financial sustainability and strengthen the scientific and research role of the institution, in line with the priorities of the national health policy. The work also included studying the performance and budget project for the year 2026, and approving the draft internal regulations of the Board of Directors in accordance with the recommendations of the audit committee, in addition to making a number of organizational decisions related to the management of the institution. In a guiding speech on the occasion, the minister stressed the strategic position held by the Serum and Vaccine Center within the national health system, given its scientific and historical record and its specialized human competencies. He affirmed that the Institute represents a fundamental pillar for strengthening the health and pharmaceutical sovereignty of the Kingdom, in line with the high royal directives. Tahraoui explained that the next phase will witness a renewed vision for the role of the Pasteur Institute of Morocco, based on supporting public investment in scientific research and innovation, and strengthening cooperation with various national and international actors, in a way that ensures directing pharmaceutical and vaccine research towards meeting priority health needs, and serving public policies in the health field. The minister also highlighted the pivotal roles played by the Institute in the areas of epidemiological surveillance, combating infectious diseases, and research in biomedical medicine, noting that these tasks are of increasing importance in light of global health transformations. This, in his words, necessitates the continued development of infrastructure, the valorization of human capital, and the expansion of strategic partnerships, especially with the private sector and research institutions. In conclusion of his speech, the minister praised the involvement of the Institute's cadres and the spirit of responsibility that characterizes their performance, stressing the commitment of the Ministry of Health and Social Protection to support this national institution and strengthen its capabilities, and to consolidate its position as a reference and reliable center at the national and regional levels, in a way that contributes to improving the health of citizens and enhancing confidence in the national health system.
